Sugi Predict

Sugi Predict / Compounds / SCHEMBL16615839

SCHEMBL16615839

SCHEMBL16615839

Cc1ncc(CNC(=O)c2ccc(CNS(=O)(=O)c3cc4ccccc4s3)cn2)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN2A Q12879 4/20 0.49
▸ GRIN1 Q05586 2/20 0.49
▸ GRIN2B Q13224 1/20 0.48
▸ TPSAB1 Q15661 1/20 0.39
▸ SCD O00767 2/20 0.38
▸ MALT1 Q9UDY8 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ PDCD1 Q15116 1/20 0.35
▸ CD274 Q9NZQ7 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ DRD2 P14416 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ HTR6 P50406 1/20 0.35
▸ GUSB P08236 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16615900 0.88 GRIN2A (0.61) GRIN2AGRIN1GRIN2BTPSAB1DRD2
SCHEMBL16615836 0.84 GRIN2A (0.49) GRIN2AGRIN1GRIN2BALDH1A1MEN1
SCHEMBL16615803 0.83 GRIN2A (0.52) GRIN2AGRIN1GRIN2BALDH1A1HTT
SCHEMBL16598218 0.81 GRIN2A (0.55) GRIN2AGRIN1GRIN2BSCDALDH1A1
SCHEMBL16615806 0.81 GRIN2A (0.61) GRIN2AGRIN1GRIN2BSCDALDH1A1
SCHEMBL16615830 0.81 GRIN2A (0.59) GRIN2AGRIN1GRIN2BSCDALDH1A1
SCHEMBL16615838 0.81 GRIN2A (0.47) GRIN2AGRIN1GRIN2BSCDALDH1A1
SCHEMBL16598435 0.81 GRIN2A (0.61) GRIN2AGRIN1GRIN2BALDH1A1HTT
SCHEMBL16598144 0.80 GRIN2A (0.60) GRIN2AGRIN1GRIN2BSCDALDH1A1
SCHEMBL16615835 0.80 KMT2A (0.53) GRIN2AGRIN1GRIN2BALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963434-B2 N-arylmethyl sulfonamide negative modulators of NR2A LUC THERAPEUTICS, INC. (US) 2018-05-08 — — US disclosed
US-9963434-B2 N-arylmethyl sulfonamide negative modulators of NR2A LUC THERAPEUTICS, INC. (US) 2018-05-08 — — US disclosed
US-20160311782-A1 N-ARYLMETHYL SULFONAMIDE NEGATIVE MODULATORS OF NR2A NOVARTIS AG (CH) 2016-10-27 — — US disclosed
US-20160311782-A1 N-ARYLMETHYL SULFONAMIDE NEGATIVE MODULATORS OF NR2A NOVARTIS AG (CH) 2016-10-27 — — US disclosed
US-20150141433-A1 N-ARYLMETHYL SULFONAMIDE NEGATIVE MODULATORS OF NR2A MNEMOSYNE PHARMACEUTICALS, INC. 2015-05-21 — — US disclosed
US-20150141433-A1 N-ARYLMETHYL SULFONAMIDE NEGATIVE MODULATORS OF NR2A MNEMOSYNE PHARMACEUTICALS, INC. 2015-05-21 — — US disclosed
WO-2015048503-A2 N-ARYLMETHYL SULFONAMIDE NEGATIVE MODULATORS OF NR2A MNEMOSYNE PHARMACEUTICALS, INC. (US) 2015-04-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311782-A1 N-ARYLMETHYL SULFONAMIDE NEGATIVE MODULATORS OF NR2A GRIN2A, GRIN2B, NR2C2 GRIN2A 1/4885GRIN1 5/4885GRIN2B 2/4885
US-20150141433-A1 N-ARYLMETHYL SULFONAMIDE NEGATIVE MODULATORS OF NR2A GRIN2A, GRIN2B, NR2C2 GRIN2A 1/4885GRIN1 5/4885GRIN2B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.